The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors
Abstract
Currently no objective grading system for pulmonary adenocarcinomas exists. To determine whether specific histologic patterns or combinations thereof could be linked to an objective grading system, the histologic patterns in metastatic tumor deposits was compared with the patterns seen in the corresponding 73 primary tumor to determine whether a specific pattern had higher propensity to metastasize. The concordance of the predominant histologic pattern in the primary tumor and the metastases was of 100% for micropapillary, 86% for solid, 42% for acinar, and 23% for papillary types of adenocarcinoma. Informed by these results, a 3-tier grading system based on the histologic subtypes was established. Grade I, a pattern with low metastatic potential (BAC); Grade II, patterns with intermediate metastatic potential (acinar and papillary); and Grade III, patterns with high metastatic potential (solid and micropapillary). These grades were combined into a number of different scoring systems, whose ability to predict recurrence or death from disease was tested in 366 stage 1 adenocarcinomas. A score based on the 2 most predominant grades was able to stratify patients into low-to-high risk for recurrence or death of disease (P=0.001). The 5-years disease-free survival for patients in the highest score group was of 0.73, compared with 0.84 and 0.92 in the intermediate and lowest score groups. Concordance probability estimate was 0.65 (95% confidence interval 0.57-0.73). Therefore, this scoring system provides valuable information in discriminating patients with different risk of disease-recurrence in a highly homogeneous population of patients with stage I cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer
Potti, A., Mukherjee, S., Petersen, R., Dressman, H. K., Bild, A., Koontz, J., Kratzke, R., Watson, M. A., Kelley, M., Ginsburg, G. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060467 · Cited by 576
RetractedGoldstraw, P., Crowley, J., Chansky, K., Giroux, D. J., Groome, P. A., Rami-Porta, R., Postmus, P. E., Rusch, V., & Sobin, L. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31812f3c1a · Cited by 3,655
Self-citationEpstein, J. I., Allsbrook, W. C., Amin, M. B., & Egevad, L. L. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000173646.99337.b1 · Cited by 2,763
Prognostic significance of morphologic parameters in renal cell carcinoma
Fuhrman, S. A., Lasky, L. C., & Limas, C. (1982) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198210000-00007 · Cited by 2,724
Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma (2008) · Nature Medicine · doi:10.1038/nm.1790 · Cited by 1,190
Small adenocarcinoma of the lung. Histologic characteristics and prognosis
Noguchi, M., Morikawa, A., Kawasaki, M., Matsuno, Y., Yamada, T., Hirohashi, S., Kondo, H., & Shimosato, Y. (1995) · Cancer · doi:10.1002/1097-0142(19950615)75:12<2844::aid-cncr2820751209>3.0.co;2-# · Cited by 1,134
A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer
Chen, H.-Y., Yu, S.-L., Chen, C.-H., Chang, G.-C., Chen, C.-Y., Yuan, A., Cheng, C.-L., Wang, C.-H., Terng, H.-J., Kao, S.-F., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060096 · Cited by 935
Concordance probability and discriminatory power in proportional hazards regression
Gönen, M., & Heller, G. (2005) · Biometrika · doi:10.1093/biomet/92.4.965 · Cited by 673
Prognostic Significance of Nottingham Histologic Grade in Invasive Breast Carcinoma
Rakha, E. A., El-Sayed, M. E., Lee, A. H. S., Elston, C. W., Grainge, M. J., Hodi, Z., Blamey, R. W., & Ellis, I. O. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.5986 · Cited by 628
Hoffman, P. C., Mauer, A. M., & Vokes, E. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)82038-3 · Cited by 605
Motoi, N., Szoke, J., Riely, G. J., Seshan, V. E., Kris, M. G., Rusch, V. W., Gerald, W. L., & Travis, W. D. (2008) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31815cb162 · Cited by 371
Self-citationThree-gene prognostic classifier for early-stage non small-cell lung cancer
Lau, S. K., Boutros, P. C., Pintilie, M., Blackhall, F. H., Zhu, C.-Q., Strumpf, D., Johnston, M. R., Darling, G., Keshavjee, S., Waddell, T. K., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0352 · Cited by 255
Tomida, S., Takeuchi, T., Shimada, Y., Arima, C., Matsuo, K., Mitsudomi, T., Yatabe, Y., & Takahashi, T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.7053 · Cited by 242
Prognostic gene signatures for non-small-cell lung cancer
Boutros, P. C., Lau, S. K., Pintilie, M., Liu, N., Shepherd, F. A., Der, S. D., Tsao, M.-S., Penn, L. Z., & Jurisica, I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809444106 · Cited by 205
Invasive Size is an Independent Predictor of Survival in Pulmonary Adenocarcinoma
Borczuk, A. C., Qian, F., Kazeros, A., Eleazar, J., Assaad, A., Sonett, J. R., Ginsburg, M., Gorenstein, L., & Powell, C. A. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318190157c · Cited by 186
Advances in Chemotherapy of Non-small Cell Lung Cancer
Molina, J. R., Adjei, A. A., & Jett, J. R. (2006) · Chest · doi:10.1378/chest.130.4.1211 · Cited by 165
Histologic features are important prognostic indicators in early stages lung adenocarcinomas
Yim, J. H., Zhu, L., Chiriboga, L. A., Watson, H. N., Goldberg, J. D., & Moreira, A. L. (2006) · Modern Pathology · doi:10.1038/modpathol.3800734 · Cited by 147
Self-citationMolecular and pathologic markers in stage I non-small-cell carcinoma of the lung.
Strauss, G. M., Kwiatkowski, D. J., Harpole, D. H., Lynch, T. J., Skarin, A. T., & Sugarbaker, D. J. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.5.1265 · Cited by 140
Prognostic significance of grading in lung adenocarcinoma
Barletta, J. A., Yeap, B. Y., & Chirieac, L. R. (2009) · Cancer · doi:10.1002/cncr.24831 · Cited by 136
Staging classification of lung cancer: A Critical Evaluation
Mountain, C. F. (2002) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00063-7 · Cited by 88
Morgensztern, D., Waqar, S. N., Subramanian, J., Gao, F., & Govindan, R. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181ba3634 · Cited by 84
Petersen, I., Kotb, W. F. M. A., Friedrich, K.-H., Schlüns, K., Böcking, A., & Dietel, M. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2008.12.013 · Cited by 77
Riquet, M., Foucault, C., Berna, P., Assouad, J., Dujon, A., & Danel, C. J. (2006) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.01.021 · Cited by 66
Cited by
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y., Beer, D. G., Powell, C. A., Riely, G. J., Van Schil, P. E., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318206a221 · Cited by 4,792
Self-citationThe 2015 World Health Organization Classification of Lung Tumors
Travis, W. D., Brambilla, E., Nicholson, A. G., Yatabe, Y., Austin, J. H. M., Beasley, M. B., Chirieac, L. R., Dacic, S., Duhig, E., Flieder, D. B., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000630 · Cited by 4,520
Self-citationNaidich, D. P., Bankier, A. A., MacMahon, H., Schaefer-Prokop, C. M., Pistolesi, M., Goo, J. M., Macchiarini, P., Crapo, J. D., Herold, C. J., Austin, J. H., et al. (2013) · Radiology · doi:10.1148/radiol.12120628 · Cited by 1,000
Self-citationYoshizawa, A., Motoi, N., Riely, G. J., Sima, C. S., Gerald, W. L., Kris, M. G., Park, B. J., Rusch, V. W., & Travis, W. D. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.232 · Cited by 976
Self-citationGoldstraw, P., Ball, D., Jett, J. R., Le Chevalier, T., Lim, E., Nicholson, A. G., & Shepherd, F. A. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62101-0 · Cited by 711
Metadata
- Authors
- Sica, G., Yoshizawa, A., Sima, C. S., Azzoli, C. G., Downey, R. J., Rusch, V. W., Travis, W. D., & Moreira, A. L.
- Venue
- American Journal of Surgical Pathology
- Published
- 2010-08
- Volume
- 34
- Issue
- 8
- Pages
- 1155-1162
- ISSN
- 0147-5185 (ISSN-L)
- OpenAlex
- W2034346990
- Cited by
- 325
- References
- 23
- FWCI
- 17.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.